Treating Intracranial Aneurysms with the CODMAN ENTERPRISE® Device: RIA Neurovascular:

NANO: Effectiveness and Safety of Small Aneurysm Coiling Trial

This is a prospective study to compare the safety and efficacy of treating small aneurysms.

ATLAS: Next Generation Treatment for Intracranial Aneurysms

Safety and Effectiveness of the Treatment of Wide-Neck, Intracranial, Saccular Aneurysms with the Next Generation Neuroform Stent System.

COMPASS Trial: A Direct Aspiration First Pass Technique

Intravenous (IV) tissue plasminogen activator (tPA) administration has been shown to be safe and effective for treatment of Acute Ischemic Stroke (AIS) within 3 hours of symptom onset, and newer evidence has shown potential benefit out to 4.5 hours.

StrokeNet: Developed by the National Institute of Health

StrokeNet, developed by NIH, is the new structure for federal funding of all aspects of stroke research including prevention, acute treatment, and recovery / rehabilitation.

We Are Committed to Clinical Research

RIA has a rich history of participation in clinical research and innovation dating back to the 1980s. Many of our physicians believe it is important to contribute to science and advance medicine.

Barrel™: Study of the Reverse Medical Barrel™ Vascular Reconstruction Device

The full name of this study is: Barrel™: Study of the Reverse Medical Barrel™ Vascular Reconstruction Device for Adjunctive Treatment to Embolic Coils for Wide-Neck, Intracranial, Bifurcating/Branching Aneurysms.

Treating Intracranial Aneurysms with the CODMAN ENTERPRISE® Device

A Prospective, Multi-Center, Single Arm Study to evaluate the Safety and Effectiveness of the CODMAN ENTERPRISE® Vascular Reconstruction Device and Delivery System when used in conjunction with Endovascular Coil Embolization in the Treatment of Wide-Necked Saccular Intracranial Aneurysms.